These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6871468)

  • 1. Alloimmunization prevents the migration of transfused indium-111-labeled granulocytes to sites of infection.
    Dutcher JP; Schiffer CA; Johnston GS; Papenburg D; Daly PA; Aisner J; Wiernik PH
    Blood; 1983 Aug; 62(2):354-60. PubMed ID: 6871468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of histocompatibility factors on pulmonary retention of indium-111-labeled granulocytes.
    Dutcher JP; Riggs C; Fox JJ; Johnston GS; Norris D; Wiernik PH; Schiffer CA
    Am J Hematol; 1990 Apr; 33(4):238-43. PubMed ID: 2316507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Granulocyte transfusion.
    Atallah E; Schiffer CA
    Curr Opin Hematol; 2006 Jan; 13(1):45-9. PubMed ID: 16319687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term follow-up patients with leukemia receiving platelet transfusions: identification of a large group of patients who do not become alloimmunized.
    Dutcher JP; Schiffer CA; Aisner J; Wiernik PH
    Blood; 1981 Nov; 58(5):1007-11. PubMed ID: 6794674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serological studies in patients on platelet- and granulocyte-substitution therapy.
    Pegels JG; Bruynes EC; Engelriet CP; von dem Borne AE
    Br J Haematol; 1982 Sep; 52(1):59-68. PubMed ID: 7115629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A flow cytometric platelet immunofluorescence crossmatch for predicting successful HLA matched platelet transfusions.
    Sintnicolaas K; Löwenberg B
    Br J Haematol; 1996 Mar; 92(4):1005-10. PubMed ID: 8616059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serial measurement of lymphocytotoxic antibody and response to nonmatched platelet transfusions in alloimmunized patients.
    Lee EJ; Schiffer CA
    Blood; 1987 Dec; 70(6):1727-9. PubMed ID: 3479195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between alloimmunization and posttransfusion granulocyte survival: experience in a chronic granulomatous disease cohort.
    Heim KF; Fleisher TA; Stroncek DF; Holland SM; Gallin JI; Malech HL; Leitman SF
    Transfusion; 2011 Jun; 51(6):1154-62. PubMed ID: 21175646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of lymphocytotoxic antibody reactivity on the results of single antigen mismatched platelet transfusions to alloimmunized patients.
    Hussein MA; Lee EJ; Fletcher R; Schiffer CA
    Blood; 1996 May; 87(9):3959-62. PubMed ID: 8611727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alloimmunization following prophylactic granulocyte transfusion.
    Schiffer CA; Aisner J; Daly PA; Schimpff SC; Wiernik PH
    Blood; 1979 Oct; 54(4):766-74. PubMed ID: 476300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response to granulocyte transfusions in the alloimmunized patient.
    Dahlke MB; Keashen MA; Alavi JB; Koch PA; Okpara RA
    Transfusion; 1980; 20(5):555-8. PubMed ID: 6999685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous immune globulin for patients alloimmunized to random donor platelet transfusion.
    Lee EJ; Norris D; Schiffer CA
    Transfusion; 1987; 27(3):245-7. PubMed ID: 3590287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Donor selection for alloimmunized patients by platelet crossmatching of random-donor platelet concentrates.
    O'Connell BA; Schiffer CA
    Transfusion; 1990 May; 30(4):314-7. PubMed ID: 2349631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Granulocyte transfusions and outcome of alloimmunized patients with gram-negative sepsis.
    Dahlke MB; Keashen M; Alavi JB; Koch PA; Eisenstaedt R
    Transfusion; 1982; 22(5):374-8. PubMed ID: 6750875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Independent roles for platelet crossmatching and HLA in the selection of platelets for alloimmunized patients.
    Friedberg RC; Donnelly SF; Mintz PD
    Transfusion; 1994 Mar; 34(3):215-20. PubMed ID: 8146893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized clinical trial of granulocyte transfusions for infection in acute leukemia.
    Alavi JB; Root RK; Djerassi I; Evans AE; Gluckman SJ; MacGregor RR; Guerry D; Schreiber AD; Shaw JM; Koch P; Cooper RA
    N Engl J Med; 1977 Mar; 296(13):706-11. PubMed ID: 320477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of HLA and platelet-reactive antibodies in alloimmunized patients refractory to platelet therapy.
    Brubaker DB; Romine M
    Am J Hematol; 1987 Dec; 26(4):341-52. PubMed ID: 3687931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid migration of 111indium-labeled granulocytes to sites of infection.
    Dutcher JP; Schiffer CA; Johnston GS
    N Engl J Med; 1981 Mar; 304(10):586-9. PubMed ID: 7453726
    [No Abstract]   [Full Text] [Related]  

  • 19. Granulocyte transfusion kinetics measured by chemiluminescence, nitroblue tetrazolium reduction, and recovery of indium-111-labeled granulocytes.
    Elliott GR; Clay ME; Mills EL; Abramson JS; McCullough J; Quie PG
    Transfusion; 1987; 27(1):23-7. PubMed ID: 3810820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ineffectiveness of random donor platelet transfusion in splenectomized, alloimmunized recipients.
    Hogge DE; Dutcher JP; Aisner J; Schiffer CA
    Blood; 1984 Jul; 64(1):253-6. PubMed ID: 6733276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.